Once-daily amoxicillin approved

January 25, 2008

Moxatag 775 mg (amoxicillin extended-release, MiddleBrook Pharmaceuticals) has been approved to treat adults and children 12 and older with pharyngitis and/or tonsillitis secondary to strep throat. MiddleBrookclaims that its product is the first once-daily amoxicillin product approved in this country. Its convenient dosing should ensure better drug compliance.

Written by fred · Filed Under Drugs